Healthcare • Diagnostics & Research
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if BLLN is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
28 top institutions tracked
Last 13F trend: accumulating (heavy)
Unlock crowding heatmapUnlock filer discoverySentiment: bearish
Last trade: sell 8 days ago
Red flags: 1
156 filers reported a long position in BLLN for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| ADAMS STREET PARTNERS LLC | $205.3M | 1.7M | Unchanged |
| PRICE T ROWE ASSOCIATES INC /MD/ | $121.2M | 1M | +37% |
| BAILLIE GIFFORD & CO | $108.2M | 901.4K | -28.5% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $100.9M | 841K | +456.1% |
| Invesco Ltd. | $100.3M | 835.6K | +105.6% |
| VANGUARD CAPITAL MANAGEMENT LLC | $95.9M | 799.5K | +338.2% |
| Neuberger Berman Group LLC | $91.7M | 764.2K | +7.8% |
| BAMCO INC /NY/ | $89M | 742.1K | +0.1% |
| WASATCH ADVISORS LP | $62.2M | 518.1K | +40.2% |
| MILLENNIUM MANAGEMENT LLC | $51M | 425K | New |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.